Skip to main content

Table 1 Distribution of novel drug approvals by designation and indication.

From: Establishing a reasonable price for an orphan drug

 

Non-oncology

Oncology

Total

Orphan drugs

36

35

71

Non-orphan drugs

58

53

111

Total

94

88

182

Back to article page

Cost Effectiveness and Resource Allocation

ISSN: 1478-7547

Contact us